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long-term life dissatisfaction burden
Teemu Rissanen1,2*, Soili M Lehto3, Jukka Hintikka2,4, Kirsi Honkalampi5, Tarja Saharinen1, Heimo Viinamäki1,3
and Heli Koivumaa-Honkanen1,3,6,7,8,9,10,11Abstract
Background: Mental health is interconnected with somatic health and can manifest itself in biological processes.
Life dissatisfaction is an indicator of subjective well-being, but information on its biological correlates is scarce.
The aim of this study was to investigate the biological correlates along with other health-related factors of
long-term life dissatisfaction in a population-based sample.
Methods: As part of the Kuopio Depression Study, health questionnaires were sent to a randomly selected
population-based sample in 1998, 1999, and 2001. In 2005, among a clinically studied sub-sample (n = 305), the
7-year long-term life dissatisfaction burden was assessed by summing life satisfaction scores from previous health
questionnaires. Several sociodemographic, health, health behavior, and biological factors were investigated in
respect to their associations to categorized (low and high) and continuous (linear regression) life satisfaction burden
score (higher values indicating dissatisfaction).
Results: In the final linear regression model long-term life dissatisfaction burden was significantly associated with
poor social support (B = 0.138; p < 0.001), marital status (i.e. living alone) (B = 0.049; p = 0.019), current smoking
(B = 0.087; p < 0.001), poor sleep (B = 0.052; p = 0.001), use of statins (B = −0.052; p = 0.002) and lower serum
adiponectin level (B = −0.001; p = 0.039) whereas association of metabolic syndrome was marginally nonsignificant
(B = 0.029; p = 0.055).
Conclusion: Long-term life dissatisfaction is associated with adverse health, health behavioral, and social factors,
as well as with a decreased anti-inflammatory buffer capacity, all indicating close relationships between subjective
well-being and somatic morbidity.
Keywords: Life satisfaction, Burden, Social support, Inflammation, Adiponectin, Metabolic syndromeBackground
Subjective well-being [1] is one of the main dimensions
of good mental health. In longitudinal studies, self-
reported life dissatisfaction has shown to be an indicator
of long-term health hazards, i.e. increased mortality [2],
including suicides [3] and unintentional injuries [4],
work disability [5], and diseases such as coronary heart
disease [6]. Cross-sectionally, life satisfaction is positively
related to health, self-perceived wealth [7,8], better psy-
chosocial functioning [9], and especially with social
support [8,10-13].* Correspondence: teemu.rissanen@fimnet.fi
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reproduction in any medium, provided the orThe association between mental health and biological
processes, especially inflammation, has recently become
an important research topic. Negative relationships with
others and a lack of purpose in life have previously been
linked with a higher level of inflammation, for instance
with the serum level of proinflammatory cytokine IL-6
in population-based studies [14,15]. Poor sleep quality,
impaired sleep [16,17], and chronic psychological stress
have also been linked with inflammation [18-20]. On the
other hand, stressful life changes, health stress, a high
body mass index and poor quality of sleep have been re-
lated to lower life satisfaction among women [21]. How-
ever, better knowledge is needed of the link between
inflammatory factors and life satisfaction [22].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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by adipose tissue [23,24]. Adiponectin acts in an anti-
inflammatory manner [25,26], in contrast to proinflam-
matory resistin, and more conventional proinflammatory
cytokines such as interleukin (IL)-6 and tumor necrosis
factor (TNF)-α. Inflammation and cytokine responses
have previously been associated with psychological stress
[19,20]. Lowered serum adiponectin levels have been ob-
served in major depressive disorder [27], panic disorder
[28], and schizophrenia [29]. Moreover, among elderly
patients with major depressive disorder, serum levels of
adiponectin were lower than in non-depressed subjects
[30]. However, the possible biological alterations do not
follow categories of psychiatric diagnosis. For example,
cytokine alterations in different diagnostic categories
have closely resembled each other. Thus, evaluation of
the inflammatory state with regard to global well-being
is needed. In an English longitudinal study on ageing,
well-being was noted to relate to low central adiposity in
men, whereas in women it was related to a low level of
the inflammatory marker hs-CRP [22]. Another previous
study has reported an association between childhood
maltreatment and lowered serum adiponectin levels [31].
Health-related factors such as obesity, metabolic syndrome,
coronary heart disease, and the risk of cancer [24,32-34]
have also been linked with levels of adiponectin.
The aim of this study was to investigate the biological
and other health-related correlates of the long-term life
dissatisfaction burden in a population-based sample. This
may help to improve understanding of the relationships
between subjective well-being and somatic morbidity.
Such understanding may offer a potential for early inter-
ventions and the prevention of adverse biological and
physiological changes.
Methods
This study was conducted as part of the four-phase
Kuopio Depression Study (KUDEP) focusing on the
mental health of general population adults aged 25 to
64 years in the province of Kuopio in Eastern Finland.
The study protocol was approved by the Research Ethics
Committee of Kuopio University Hospital and the Uni-
versity of Kuopio. All subjects provided written informed
consent before entering the study.
In 1998, a random sample of 3004 participants was
selected from the National Population Register and
followed up in 1999 and 2001. The baseline sample in
1998 included 2050 participants (response rate 68%), the
first follow-up sample (in 1999) 1722 participants, and
the second follow-up sample (in 2001) included 1593 re-
spondents. The follow-up questionnaire was only sent to
those participants who responded at baseline or in 1999.
In the fourth study phase in 2005, a sub-sample (n =
427) of the participants was invited for clinical evaluationand laboratory testing [35]. The inclusion criteria for this
sub-sample were based on self-reported adverse mental
symptoms or features, i.e. depression measured with the
21-item Beck Depression Inventory (BDI) [36], alexithymic
features measured with the 20-item Toronto Alexithymic
Scale (TAS) [37-39], and life dissatisfaction measured with
the 4-item life satisfaction scale (LS) [2,40]. The following
cut-offs were used: BDI > 9 [36], TAS > 57 [39], and LS > 11
[2]. Half of the selected subjects in the present study
belonged to the symptomatic group (n = 209; 48.9%) and
half to the asymptomatic group (n = 218; 51.1%). There
were no differences between the groups in the gender dis-
tribution (females: 58% vs. 56%; p = ns) or age (mean (SD):
55.3 (9.0) years vs. 56.3 (10.1) years; p = ns). The participa-
tion rate in interviews was 78% (n = 333). Twenty-eight
cases provided inadequate data and were excluded. The
final sample included 305 cases, of which 175 (57.4%) were
females and 130 (42.6%) males.
In the questionnaire in 2005, participants reported
their age, gender, marital status (married or living with a
partner vs. unmarried, separated or divorced, widowed,
other), alcohol use (≥2 times per week vs. less), and
current smoking (yes/no). Subjectively assessed social
support (good/normal vs. poor), quality of sleep (good/
normal vs. poor), and the presence of previous physician-
given diagnoses of coronary heart disease (yes/no), hyper-
tension (yes/no), cancer (yes/no), and rheumatoid arthritis
(yes/no) were reported. Metabolic syndrome is a cluster of
risk factors that include abdominal obesity, hyperglycemia,
hypertension, low HDL, and high triglycerides. It was di-
agnosed according to modified criteria of the National
Cholesterol Education Program Adult Treatment Panel III
(NCEP ATP III) as described elsewhere [41]. Addition-
ally, information on the usage of oral corticosteroids
(yes vs. no), statins (yes vs. no), and nonsteroidal anti-
inflammatory drugs [NSAID (yes vs. no)] was obtained
from the questionnaire, as well as the register of the na-
tionwide Social Insurance Institute.
Life satisfaction was assessed with a self-reported 4-
item life satisfaction scale (LS-4, range 4–20, higher
scores indicating lower life satisfaction). It has been
used in general and patient populations [2,3,8,42,43].
The study subjects rated their general interest and hap-
piness in life, ease of living, and experiences of loneli-
ness, respectively, with the following scores: 1 = very
interesting/happy/easy/not at all lonely; 2 = fairly inter-
esting/happy/easy; 3 = cannot say/missing data; 4 = fairly
boring/unhappy/hard/lonely; 5 = very boring/unhappy/
hard/lonely. Psychometric properties of the 4-item life
satisfaction scale have been reported in more detail
elsewhere [2,5,8,44].
A long-term life dissatisfaction burden score was
calculated based on the sum of LS scores in the four
follow-up assessments (1998, 1999, 2001 and 2005). The
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the median score: the long-term satisfied (range 16–33;
n = 159; 52.1%) and the long-term dissatisfied (range
34–80; n = 146; 47.9%) for the purpose of examining
crude group differences. The mean LS scores (95% con-
fidence intervals) in the long-term satisfied group during
the follow-up were as follows: 1998: 6.96 (6.77–7.16);
1999: 6.85 (6.61–7.09); 2001: 6.69 (6.48–6.91); 2005: 6.45
(6.24–6.67). The respective figures for the long-term
dissatisfied group were: 1998: 12.68 (12.16–13.21); 1999:
12.43 (11.87–12.99); 2001: 12.16 (11.64–12.68) and 2005:
11.14 (10.58–11.71. To verify the results, groups were
formed consisting of the “stable satisfied” (LS score
1998 ≤ 11 and LS score 2005 ≤ 11; n = 197) and the
“stable dissatisfied” (LS score 1998 ≥ 12 and LS score
2005 ≥ 12; n = 51). In the multivariate linear regression
analyses, continuous score for long-term life dissatisfac-
tion burden was used (c.f. statistical methods).
The laboratory measurements took place in the
accredited Kuopio University Hospital medical labora-
tory. The body mass index (kg/m2) was calculated from
height and body weight measured in light clothing with-
out shoes. Venous blood samples were drawn after a 12-h
overnight fast. The samples were frozen after the blood
draw, and stored at −80°C until run. The levels of IL-6
(pg/ml) and TNF-α (pg/ml) were analyzed by multiplexing
with Bio-Plex Human Cytokine Panel 1, utilizing a Bio-
Plex instrument based on Luminex xMAP technology
(Bio-Rad Laboratories Inc., Hercules, California, USA).
High-sensitivity C-reactive protein (hsCRP) was deter-
mined by an immunoturbidimetric method (Konelab CRP,
code 981699; Thermo Electron Co., Finland). The samples
were analyzed using a Konelab 60i clinical chemistry
analyzer (Thermo Electron). Adiponectin and resistin
were quantified with a human serum adipokine (Panel A)
LincoPlex kit (Millipore, MA, USA) using a Bio-Plex
Suspension Array System (Bio-Rad Laboratories Pty Ltd,
Hercules, CA, USA). The assay conditions were con-
trolled, standardized, and pre-optimized to ensure optimal
repeatability and reproducibility of the assays. Further-
more, the kit instructions and instrument manuals were
carefully followed. The assayed kits were from the same
lot, which allows better control of inter-assay variability.
The samples were measured as a batch at the end of the
study. The analysis process has been reported more pre-
cisely in previous studies [31,45].
Statistical methods
Data analysis was carried out using SPSS (version 17.0).
The differences in proportions were examined with the
Pearson chi-squared test for categorical variables. As
continuous variables did not follow a normal distribu-
tion, the group differences were assessed with the
Mann–Whitney U-test. Both Pearson and Spearmancorrelations were used to study associations between
continuous variables.
A logarithmic transformation was done for continuous
life dissatisfaction burden score (logLSburd) due to its
non-normal distribution. The correlates of long-term life
dissatisfaction burden were assessed with linear regression
models. Firstly, the crude associations between long-term
dissatisfied and sociodemographic and health-related
factors, including inflammatory biomarkers were studied.
Secondly, based on these bivariate analyses, the significant
correlates were gathered into two age- and gender-
adjusted multivariate linear regression models (model 1
and model 2) (method: enter) (Tables 1 and 2). Model 1
(Table 1) investigated the role of sociodemographic factors
and health behavior (i.e. age, gender, marital status, social
support, sleep, and current smoking). Model 2 (Table 2)
investigated the role of various biological and health-
related factors (i.e. age, gender, metabolic syndrome, use
of statins, and serum adiponectin level). The final model
(Table 3) included all the significant correlates of long-
term life dissatisfaction from models 1 and 2 (i.e. marital
status, sleep, social support, current smoking, serum
adiponectin level, metabolic syndrome, and the use of
statins). Since active cancer may affect the inflammatory
balance (32), additional analyses were performed to assess
the association between the cancer diagnosis and inflam-
matory markers.
Results
The respondents in the long-term dissatisfied group
reported more often living alone, experiencing poor
social support and poor sleep, and were more often
current smokers compared to the long-term satisfied
(Table 4). Metabolic syndrome was more prevalent, but
the use of statins less frequent among the long-term dis-
satisfied. No significant differences were found in the
use of NSAIDs or oral corticosteroids, in gender, alcohol
consumption, or the prevalence of coronary heart dis-
ease, rheumatoid arthritis, or cancer with respect to the
long-term life dissatisfaction burden.
The anti-inflammatory cytokine adiponectin was sig-
nificantly lower among the long-term dissatisfied (p =
0.014) compared to the long-term satisfied. The levels of
proinflammatory markers TNF-α, IL-6, resistin and hs-
CRP were also higher in the long-term satisfied, but stat-
istical significance was not reached. In further analyses,
no significant association was found between the use of
statins (yes vs. no) and the inflammatory markers, i.e.
the level (mean; 95% confidence intervals) of adiponectin
[μg/ml] (14.3; 10.5–18.1 vs. 16.9; 14.9–19.0; Z = −1.76; p =
ns), resistin [ng/ml] (10.4; 8.6–12.3 vs. 11.1; 10.0–12.2; Z =
−0.29; p = ns), hs-CRP [mg/l] (3.1; 1.9–4.3 vs. 2.9; 2.4–3.4;
Z = −0.64; p = ns), IL-6 [pg/ml] (4.3; 1.2–7.5 vs. 3.8; 2.4–
5.2; Z = −0.09; p = ns) and TNF-α [pg/ml] (7.3; 1.2–13.4 vs.
Table 1 Socio-demographic factors and health behavior as correlates of long-term life dissatisfaction burden1) in linear
regression models
Variables Bivariate model2) B (95% CI)1) p-value2) Multivariate model 13) B (95% CI)2) p-value3)
Age −0.002 (−0.004–0.000) 0.014 −0.001 (−0.002 – 0.001 ) ns
Gender (male) 0.018 (−0.016–0.051) ns 0.022 (−0.007 – 0.051) ns
Marital status (living alone) 0.077 (0.031–0.124) 0.001 0.055 (0.014–0.096) 0.009
Social support (poor) 0.179 (0.133–0.225) <0.001 0.144 (0.099–0.188) <0.001
Sleep (poor) 0.081 (0.049–0.114) <0.001 0.051 (0.021–0.080) 0.001
Smoking (yes) 0.111 (0.070–0.152) <0.001 0.098 (0.060–0.136) <0.001
Alcohol consumption ≥2/week 0.022 (−0.021–0.065) ns Nim Nim
1)Long-term life dissatisfaction burden score (logLSburden): sum of life satisfaction scores in 1998, 1999, 2001 and 2005 with logarithmic transformation.
2)Bivariate linear regression analysis separately for each variable.
3)Multiple adjusted linear regression model 1 (method: enter) included the following factors: age (continuous), gender (0 = female, 1 = male), marital status
(0 =married/living in a partnership, 1 = living alone), social support (0 = good/normal, 1 = poor), sleep (0 = good, 1 = poor), and smoking (0 = no, 1 = yes).
Nim = not included in the model due to nonsignificant association in the bivariate model.
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seen when those categorized as stable dissatisfied were
compared with those with stable satisfaction (data not
shown).
According to the additional analyses, no significant as-
sociation was found between the cancer diagnosis (yes
vs. no) and the inflammatory markers, i.e. the level (mean;
95% confidence intervals) of adiponectin [μg/ml] (15.2;
8.8–39.2 vs. 15.9; 14.2–17.7; Z = −1.03; p = ns), resistin
[ng/ml] (14.9; 0.8–29.4 vs. 10.8; 9.9–11.8; Z = −0.36; p =
ns), hs-CRP [mg/l] (2.5; 0.3–5.4 vs. 3.0; 2.5–3.5; Z = −0.36;Table 2 Biological factors and medication as correlates of lon
models
Variables Bivariate model2) B (95% CI)
Age −0.002 (−0.004–0.000)
Gender (male) 0.018 (−0.016–0.051)
Metabolic syndrome (yes) 0.038 (0.004–0.073)
Use of statins (yes) −0.062 (−0.100– -0.023)
Adiponectin, [μg/ml] −0.001 (−0.002–0.000)
Coronary heart disease (yes) −0.004 (−0.064 – 0.057)
Rheumatoid arthritis (yes) 0.041 (−0.025 – 0.106)
Hypertension (yes) 0.016 (−0.020 – 0.052)
Use of oral corticosteroids (yes) 0.056 (−0.042 – 0.153)
Use of NSAIDs (yes) −0.003 (−0.096 – 0.090)
BMI, [kg/m2] 0.003 (0.000–0.006)
Resistin, [ng/ml] 0.000 (−0.002 – 0.002)
hs-CRP, [mg/l] −0.001 (−0.004 – 0.002)
TNF-α, [pg/ml] 0.000 (0.000–0.000)
IL6, [pg/ml] 0.000 (0.000–0.001)
1)Long-term life dissatisfaction burden score: sum of life satisfaction scores in 1998,
2)Bivariate linear regression analysis separately for each variable.
3)Multiple adjusted linear model 2 (method: enter) included the following factors: a
1 = yes), use of statins (0 = no, 1 = yes), and serum adiponectin level (continuous).
Nim = not included in the model due to nonsignificant association in the bivariate m
Abbreviations: NSAID Non-steroidal anti-inflammatory drug, BMI Body mass index, hs
IL6 Interleukin 6.p = ns), IL-6 [pg/ml] (2.5; 1.8–6.9 vs. 4.0; 2.6–5.3; Z =
−0.39; p = ns) and TNF-α [pg/ml] (2.5; 0.5–5.5 vs. 11.5;
6.2–16.7; Z = −0.21; p = ns).
According to both bivariate and multivariate linear re-
gression analysis, poor sleep, living alone, current smok-
ing, and especially poor current social support were
significantly associated with long-term life dissatisfaction
(logLSburden) (Table 1). The same applied for metabolic
syndrome, the use of statins and low serum levels of
adiponectin (Table 2). On the other hand, age, gender, al-
cohol consumption, coronary heart disease, rheumatoidg-term life dissatisfaction burden1) in linear regression
p-value2) Multivariate model 23) B (95% CI) p-value3)
0.014 −0.001 (−0.003 – 0.001) ns
ns 0.029 (−0.005 – 0.064) ns
0.030 0.046 (0.010 – 0.081) 0.012
0.002 −0.064 (−0.106 – -0.023) 0.002
0.016 −0.001 (−0.002 – 0.000) 0.023
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
ns Nim Nim
1999, 2001 and 2005 with logarithmic transformation.
ge (continuous), gender (0 = female, 1 = male), metabolic syndrome (0 = no,
odel.
-CRP High-sensitivity C-reactive protein, TNF-α Tumor Necrosis Factor α,
Table 3 The association between long-term life
dissatisfaction burden1) and its significant correlates in
the final multivariate linear regression model
Variables Final model2) B (95% CI) p-value
Marital status 0.049 (0.008 – 0.090) 0.019
Sleep (poor) 0.052 (0.022 – 0.081) 0.001
Social support (poor) 0.138 (0.094 – 0.183) <0.001
Smoking (yes) 0.087 (0.049 – 0.124) <0.001
Adiponectin, [μg/ml] −0.001 (−0.002 – 0.000) 0.039
Metabolic syndrome (yes) 0.029 (−0.001 – 0.059) ns (0.055)
Use of statins (yes) −0.052 (−0-086– -0.019) 0.002
1)Long-term life dissatisfaction burden score: sum of life satisfaction scores in
1998, 1999, 2001 and 2005 with logarithmic transformation.
2)The final linear regression model (method: enter) included all the significant
factors from models 1 and 2: marital status (0 =married/living in a partnership,
1 = living alone), sleep (0 = good, 1 = poor), social support (0 = good, 1 = poor),
smoking (0 = no, 1 = yes), serum adiponectin level (continuous), metabolic
syndrome (0 = no, 1 = yes), and use of statins (0 = no, 1 = yes).
Table 4 Sociodemographic, health behavior, and biological fa
dissatisfaction burden score
Long-term life dissatisfactio
Satisfied (16–33 p.) N = 159
Variables Col% (n)
Gender (male), n (%) 42.1 (67)
Living alone, n (%) 7.5 (12)
Smoking (yes), n (%) 8.2 (13)
Alcohol consumption ≥2/week, n (%) 16.4 (26)
Social support (poor) 1.3 (2)
Sleep (poor), n (%) 42.8 (68)
Metabolic syndrome, n (%)2) 31.2 (48)
Hypertension, n (%) 28.9 (46)
Coronary heart disease, n (%) 7.5 (12)
Rheumatoid arthritis, n (%) 6.3 (10)
Cancer, n (%) 1.3 (2)
Use of oral corticosteroids, n (%) 2.5 (4)
Use of NSAIDs, n (%) 4.4 (7)
Use of statins, n (%) 30.2 (48)
Variables Mean (95% CI)
Age4) 56.9 (55.3–58.6)
BMI, [kg/m2]4) 27.1 (26.4–27.9)
Adiponectin, [μg/ml]4) 18.39 (15.59–21.19)
Resistin, [ng/ml]4) 10.26 (9.22–11.31)
hs-CRP, [mg/l]4) 2.76 (2.08–3.44)
TNF-α, [pg/ml]4) 11.03 (4.28–17.78)
IL6, [pg/ml]4) 3.53 (2.05–5.01)
1)The long-term life dissatisfaction burden score is the sum of life satisfaction score
2)Missing 6 cases; 3)Fisher’s exact test; 4)missing 23 cases; 5)Mann–Whitney U-test.
Abbreviations: NSAID Non-steroidal anti-inflammatory drug, BMI Body mass index, hs
IL6 Interleukin 6.
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mass index, and the serum proinflammatory markers
resistin, hs-CRP, TNF-α, and IL-6 were not significantly
related to logLSburden.
When correlation between continuous variables were
tested, age (Pearson 0.141, p = 0.014; Spearman 0.156, p =
0.006) and adiponectin (Pearson 0.139, p = 0.016; Spear-
man 0.133, p = 0.021) were significantly correlated with
logLSburd, while body mass index (Pearson 0.099, p = ns;
Spearman 0.081, p = ns) and proinflammatory markers
hS-CRP (Pearson 0.043, p = ns; Spearman 0.100, p = ns);
resistin (Pearson 0.021, p = ns; Spearman 0.059, p = ns);
IL6 (Pearson 0.038, p = ns; Spearman 0.072, p = ns) and
TNF-α (Pearson 0.043, p = ns; Spearman 0.072, p = ns)
were not.
In the final linear regression model (Table 3), including
all the above-mentioned significant variables from multi-
variate models 1 and 2, poor social support (B =0.138;
Beta = 0.315; t = 6.19; p < 0.001), marital status (i.e. livingctors in 2005 by two-category long-term life
n burden1)
Dissatisfied (34–80 p.) N = 146
Col% (n) p-value
43.2 (63) ns
21.9 (32) <0.001
29.5 (43) <0.001
19.9 (29) ns
24.1 (36) <0.0013)
69.2 (101) <0.001
43.4 (63) 0.028
32.2 (47) ns
8.9 (13) ns
7.5 (11) ns
2.7 (4) ns3)
3.4 (5) ns3)
2.1 (3) ns3)
16.4 (24) 0.005
Mean (95% CI) p-value
55.1 (53.6–56.6) 0.0255)
27.8 (26.8–28.8) ns5)
13.38 (11.44–15.31) 0.0145)
11.62 (9.99–13.25) ns5)
3.14 (2.43–3.85) ns5)
11.57 (3.69–19.46) ns5)
4.35 (2.15–6.56) ns5)
s in 1998, 1999, 2001 and 2005.
-CRP High-sensitivity C-reactive protein, TNF-α Tumor Necrosis Factor alpha,
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ing (B = 0.087; Beta = 0.227; t = 4.575; p < 0.001), poor
sleep (B = 0.052; Beta = 0.174; t = 3.465; p = 0.001, use of
statins (B = −0.052; Beta = −0.152; t = −3.076; p = 0.002)
and adiponectin (B = −0.001; Beta = −0.104; t = −2.070;
p = 0.039) were independently associated with higher life
dissatisfaction burden score (logLSburden) whereas asso-
ciation of metabolic syndrome was marginally insignificant
(B = 0.029; p = 0.055).
Discussion
The present study investigated the significant indepen-
dent correlates of the long-term dissatisfaction burden
from a set of sociodemographic and health-related fac-
tors, also including several biomarkers. To the best of
our knowledge, this is the first study on a general popu-
lation sample to present lowered serum adiponectin
levels in individuals experiencing long-term life dissatis-
faction. This was true also after using life dissatisfaction
burden as a continuous score in a multivariate linear re-
gression model including significant sociodemographic
and health-related factors such as BMI, metabolic syn-
drome and the use of statins. Still, poor social support
was the strongest correlate of the long-term life dissatis-
faction burden, which is consistent with previous re-
search [11,46]. This was true independent from marital
status, a significant correlate, too. Poor sleep was also an
independent correlate of life dissatisfaction in the model
including adiponectin, but it has also been reported to
have its own predictive ability in relation to inflamma-
tion processes [16,17,20].
Chronic psychological stress, in general, has been
linked with inflammation [18], for instance through ele-
vated levels of IL-6 and hs-CRP [19,20]. This was not
verified in our data with statistical significance, but our
findings suggest that the long-term life dissatisfaction
burden presents a form of psychological stress, which
may modulate inflammation processes by reducing the
levels of the anti-inflammatory marker adiponectin. How-
ever, more research on this is needed with larger general
population samples and with longitudinal and more de-
tailed data, which would allow further study of the mecha-
nisms behind these associations.
The health status is strongly associated with life
satisfaction [47]. The long-term life dissatisfaction bur-
den may compromise somatic health in various ways.
Current smoking in addition to poor sleep and not liv-
ing in a partnership were associated with long-term life
dissatisfaction. On the other hand, inflammatory patho-
genesis involved in metabolic syndrome can also affect
the central nervous system, even predisposing individ-
uals to brain dysfunction [48]. Thus, its role should also
be investigated further in relation to global well-being.
In the present study, metabolic syndrome was marginallynot a significant factor in the final model, and it did not
explain the observed relationship between adiponectin
and long-term life dissatisfaction.
The use of statins was significantly less frequent
among individuals with long-term life dissatisfaction,
even though they had a higher prevalence of metabolic
syndrome. This might suggest poor somatic health care
among the dissatisfied. Previously, a decreasing level of
health care has been reported in relation to an increas-
ing severity of mental disorders [49], but causality in our
findings cannot be verified. The psychosocial factors
linked with life dissatisfaction resemble those previously
found with cardiovascular disease [50,51]. Indeed, life sat-
isfaction has been significantly linked with a decreased
risk of coronary heart disease [6], which is in line with the
present study.
Health behavior also matters. Inflammation has been
observed to be lower in physically active adults [52], and
moderate physical training can modulate the cytokine
profile and improve the quality of sleep [53]. On the other
hand, smoking seems to increase low-grade inflammation,
e.g. IL-6 levels [54]. We have previously observed that
smoking is independently associated with long-term life
dissatisfaction [42]. Thus, all these associations between
long-term life dissatisfaction, health behavior, and meta-
bolic syndrome, as well as cardiovascular risk factors,
should increase the knowledge available to the physician
in preventing adverse somatic consequences among those
with low subjective well-being.
Strengths and limitations
A strength of this study was its community sample and
the availability of several important health-related mea-
sures, including biological markers, for assessing the fac-
tors related to the long-term life dissatisfaction burden
[55]. The multivariate analyses as well as taking to ac-
count of the role of the body mass index and use of
statins helped to control for potential bias. The longitu-
dinal assessment of life satisfaction provided valuable
information on cumulative burden of dissatisfaction,
while also measuring aspects of positive mental health.
Due to the somewhat small sample size and conside-
rable stability of life satisfaction in the long-term per-
spective, the changes in life satisfaction over time were
investigated to a limited extent with respect to the iden-
tified correlates. A more detailed disease history and
longitudinal data on health-related factors of the partici-
pants would have been a benefit and should be covered
in the future research.
Conclusions
Social and health behavioural factors along with stress
and inflammation play a role in life dissatisfaction, but fur-
ther research is needed to verify the biological associations
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http://www.biomedcentral.com/1471-244X/13/202found in this study. Several correlates of long-term life
dissatisfaction resembled common risk factors for somatic
diseases, supporting the close relationships between sub-
jective well-being and somatic morbidity.
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